•
A clinical worsening in CIDP may occur in concomitance with COVID-19. •
Cytokine hyperactivation triggered by SARS-CoV-2 infection might be a possible mechanism. •
The management of these patients is particularly challenging.
All Keywords
【저자키워드】 COVID-19, SARS-CoV-2, coronavirus, NEUROLOGY, Neuroimmunology, myasthenia gravis, CIDP, Polyneuropathy,
【저자키워드】 COVID-19, SARS-CoV-2, coronavirus, NEUROLOGY, Neuroimmunology, myasthenia gravis, CIDP, Polyneuropathy,